NYSE - Delayed Quote USD

DaVita Inc. (DVA)

Compare
151.91
-1.06
(-0.69%)
At close: April 1 at 4:00:02 PM EDT
144.90
-7.01
(-4.61%)
After hours: April 1 at 7:49:55 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Javier J. Rodriguez CEO & Executive Director 6.71M 23.54M 1971
Mr. Joel Ackerman CFO & Treasurer 2.11M 1.94M 1965
Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer 1.9M 3.14M 1968
Mr. James O. Hearty Chief Compliance Officer 1.25M 904.68k 1969
Mr. David Maughan Chief Operating Officer -- -- --
Mr. Christopher Michael Berry CPA Group VP & Chief Accounting Officer -- -- 1975
Ms. Madhu Narasimhan Chief Information Officer -- -- --
Nic Eliason Group Vice President of Investor Relations -- -- --
Ms. Jessica Hergenreter Chief People Officer -- -- --
Mr. Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business -- -- --

DaVita Inc.

2000 16th Street
Denver, CO 80202
United States
720-631-2100 https://www.davita.com
Sector: 
Healthcare
Full Time Employees: 
76,000

Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Corporate Governance

DaVita Inc.’s ISS Governance QualityScore as of April 1, 2025 is 1. The pillar scores are Audit: 3; Board: 2; Shareholder Rights: 3; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 30, 2025 at 10:59 AM UTC - May 5, 2025 at 12:00 PM UTC

DaVita Inc. Earnings Date

Recent Events

February 13, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

October 29, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 14, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 6, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 12, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

June 14, 2024 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

Related Tickers